Anika Therapeutics (NASDAQ:ANIK) Share Price Passes Above 200 Day Moving Average - What's Next?

robot
Abstract generation in progress

Anika Therapeutics (NASDAQ:ANIK) saw its share price move above its 200-day moving average, reaching $14.98 with a volume of 187,844 shares. Analyst sentiment is mixed but leans positive, with Barrington Research raising its price target to $17 and a consensus target price of $19. Financially, Anika Therapeutics beat Q4 earnings estimates but still posted a negative net margin and forecasted a full-year EPS of -0.84, while institutional investors own a significant 91.53% of the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin